CG
WST icon

Cynosure Group’s West Pharmaceutical WST Stock Holding History

Cynosure Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,905
Closed -$500K – 527
2025
Q3 		$500K Hold
1,905
– – 0.05% 196
2025
Q2 		$417K Sell
1,905
-8,720
-82% -$1.86M 0.05% 256
2025
Q1 		$2.38M Buy
10,625
+9,565
+902% +$2.64M 0.33% 38
2024
Q4 		$347K Sell
1,060
-7,275
-87% -$2.29M 0.05% 167
2024
Q3 		$2.5M Buy
8,335
+7,129
+591% +$2.18M 0.36% 41
2024
Q2 		$397K Buy
1,206
+253
+27% +$89.4K 0.06% 189
2024
Q1 		$377K Buy
+953
New +$353K 0.07% 148

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Cynosure Group's WST Position: Q4 2025 in Review

Cynosure Group sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 1,905 shares — an estimated $500K sold.

Cynosure Group first reported a position in WST in Q1 2024 and held it in 7 quarters. The position peaked at $2.5M in Q3 2024. 804 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • Cynosure Group reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Cynosure Group sold 1,905 West Pharmaceutical shares in Q4 2025, an estimated $500K.
  • Cynosure Group first reported a position in West Pharmaceutical in Q1 2024 and held it in 7 quarters.
  • Cynosure Group's West Pharmaceutical position peaked at $2.5M in Q3 2024.
  • 804 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on Cynosure Group's 13F filing for Q4 2025, filed 17 Feb 2026.